117 related articles for article (PubMed ID: 38092224)
1. Tumor nano-lysate activates dendritic cells to evoke a preventative immune response.
Dombroski JA; Fabiano AR; Knoblauch SV; Rowland SJ; Gibson-Corley KN; King MR
J Immunol Methods; 2024 Jan; 524():113601. PubMed ID: 38092224
[TBL] [Abstract][Full Text] [Related]
2. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
4. NOD/scid IL-2Rg(null) mice: a preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivo.
Spranger S; Frankenberger B; Schendel DJ
J Transl Med; 2012 Feb; 10():30. PubMed ID: 22364226
[TBL] [Abstract][Full Text] [Related]
5. Skin-Grafting and Dendritic Cell "Boosted" Humanized Mouse Models Allow the Pre-Clinical Evaluation of Therapeutic Cancer Vaccines.
Zeng B; Moi D; Tolley L; Molotkov N; Frazer IH; Perry C; Dolcetti R; Mazzieri R; Cruz JLG
Cells; 2023 Aug; 12(16):. PubMed ID: 37626903
[TBL] [Abstract][Full Text] [Related]
6. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
[TBL] [Abstract][Full Text] [Related]
7. Preventive cancer vaccination with P5 HER-2/neo-derived peptide-pulsed peripheral blood mononuclear cells in a mouse model of breast cancer.
Dehghan-Manshadi M; Nikpoor AR; Hadinedoushan H; Zare F; Sankian M; Fesahat F; Tahoori MT; Jaafari MR; Rafatpanah H
Biochem Cell Biol; 2021 Aug; 99(4):435-446. PubMed ID: 33395361
[TBL] [Abstract][Full Text] [Related]
8. Tissue localization of tumor antigen-loaded mouse dendritic cells applied as an anti-tumor vaccine and their influence on immune response.
Rossowska J; Pajtasz-Piasecka E; Szyda A; Zietara N; Duś D
Folia Histochem Cytobiol; 2007; 45(4):349-55. PubMed ID: 18165174
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines.
Ceglia V; Zurawski S; Montes M; Kroll M; Bouteau A; Wang Z; Ellis J; Igyártó BZ; Lévy Y; Zurawski G
Front Immunol; 2021; 12():786144. PubMed ID: 35095862
[TBL] [Abstract][Full Text] [Related]
10. Immunotheranostic microbubbles (iMBs) - a modular platform for dendritic cell vaccine delivery applied to breast cancer immunotherapy.
Jugniot N; Dahl JJ; Paulmurugan R
J Exp Clin Cancer Res; 2022 Oct; 41(1):299. PubMed ID: 36224614
[TBL] [Abstract][Full Text] [Related]
11. Tumor cell lysate-pulsed dendritic cells induce a T cell response against colon cancer in vitro and in vivo.
Wu YG; Wu GZ; Wang L; Zhang YY; Li Z; Li DC
Med Oncol; 2010 Sep; 27(3):736-42. PubMed ID: 19669608
[TBL] [Abstract][Full Text] [Related]
12. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
[TBL] [Abstract][Full Text] [Related]
13. Polymer Nanoparticle-Mediated Delivery of Oxidized Tumor Lysate-Based Cancer Vaccines.
Berti C; Graciotti M; Boarino A; Yakkala C; Kandalaft LE; Klok HA
Macromol Biosci; 2022 Feb; 22(2):e2100356. PubMed ID: 34822219
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients.
Escobar A; López M; Serrano A; Ramirez M; Pérez C; Aguirre A; González R; Alfaro J; Larrondo M; Fodor M; Ferrada C; Salazar-Onfray F
Clin Exp Immunol; 2005 Dec; 142(3):555-68. PubMed ID: 16297169
[TBL] [Abstract][Full Text] [Related]
15. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma.
Tatsumi T; Takehara T; Kanto T; Miyagi T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
Cancer Res; 2001 Oct; 61(20):7563-7. PubMed ID: 11606395
[TBL] [Abstract][Full Text] [Related]
16. Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling.
Dastmalchi F; Karachi A; Yang C; Azari H; Sayour EJ; Dechkovskaia A; Vlasak AL; Saia ME; Lovaton RE; Mitchell DA; Rahman M
J Immunother Cancer; 2019 Nov; 7(1):321. PubMed ID: 31753028
[TBL] [Abstract][Full Text] [Related]
17. Enhanced stimulation of anti-breast cancer T cells responses by dendritic cells loaded with poly lactic-co-glycolic acid (PLGA) nanoparticle encapsulated tumor antigens.
Iranpour S; Nejati V; Delirezh N; Biparva P; Shirian S
J Exp Clin Cancer Res; 2016 Oct; 35(1):168. PubMed ID: 27782834
[TBL] [Abstract][Full Text] [Related]
18. [Immunotherapeutic effects of beta-elemene combined with interleukin-23 gene-modified dendritic cells on murine pancreatic carcinoma].
Tan G; Wang ZY; Wang XG; Cheng L; Yin S
Ai Zheng; 2006 Sep; 25(9):1082-6. PubMed ID: 16965646
[TBL] [Abstract][Full Text] [Related]
19. Listeria monocytogenes activated dendritic cell based vaccine for prevention of experimental tumor in mice.
Khamisabadi M; Arab S; Motamedi M; Khansari N; Moazzeni SM; Gheflati Z; Hadjati J
Iran J Immunol; 2008 Mar; 5(1):36-44. PubMed ID: 18319523
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of antitumor vaccine in ablated hepatocellular carcinoma by high-intensity focused ultrasound.
Zhang Y; Deng J; Feng J; Wu F
World J Gastroenterol; 2010 Jul; 16(28):3584-91. PubMed ID: 20653069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
